XT
TXMD icon

XTX Topco’s TherapeuticsMD TXMD Stock Holding History

XTX Topco’s Portfolio TXMD Stock Details TXMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$47K Sell
21,246
-6,241
-23% -$12.9K ﹤0.01% 3729
2026
Q1 		$55.5K Buy
+27,487
New +$61.8K ﹤0.01% 3288
2021
Q3 		– Sell
-1,122
Closed -$67K – 1072
2021
Q2 		$67K Buy
+1,122
New +$68K 0.02% 704

Other funds holding TXMD

RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
CC
Clearline Capital New York $1.68B AUM 53.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TC
Tejara Capital London, United Kingdom $243M AUM 9.84% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

XTX Topco's TXMD Position: Q2 2026 in Review

XTX Topco reduced its TherapeuticsMD (TXMD) stake by 23% in Q2 2026, selling an estimated $12.9K and leaving 21,246 shares worth $47K. The position accounts for ﹤0.01% of the portfolio, ranked #3729.

XTX Topco first reported a position in TXMD in Q2 2021 and has held it in 3 quarters since. The position peaked at $67K in Q2 2021. 45 funds tracked by Wall St. Rank hold TXMD as of Q2 2026.

  • XTX Topco held 21,246 shares of TherapeuticsMD worth $47K as of Q2 2026.
  • XTX Topco sold 6,241 TherapeuticsMD shares in Q2 2026, an estimated $12.9K.
  • TherapeuticsMD made up ﹤0.01% of XTX Topco's portfolio in Q2 2026, its #3729 holding.
  • XTX Topco first reported a position in TherapeuticsMD in Q2 2021 and has held it in 3 quarters since.
  • XTX Topco's TherapeuticsMD position peaked at $67K in Q2 2021.
  • 45 funds tracked by Wall St. Rank held TherapeuticsMD as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.